Objective(s): Nowadays, COX-
2 inhibitors such as valdecoxib are removed from the market because of their cardiovascular toxicity and their potential to increase the risk of strokes. In response to this, medicinal chemists have attempted to synthesize new classes of COX-2 Inhibitors.
Materials and Methods:
In this study, three novel analogues of thiazolidin-4-ones derivatives ...
